ArticleBMJ case reports2012

Spironolactone, a possible selective androgen receptor modulator, should be used with caution in patients with metastatic carcinoma of the prostate.

Santhanam Sundar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.